Xiaomei Cao

509 total citations
20 papers, 415 citations indexed

About

Xiaomei Cao is a scholar working on Pharmacology, Pharmacology and Molecular Biology. According to data from OpenAlex, Xiaomei Cao has authored 20 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in Xiaomei Cao's work include Pharmacogenetics and Drug Metabolism (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Analytical Methods in Pharmaceuticals (4 papers). Xiaomei Cao is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Analytical Methods in Pharmaceuticals (4 papers). Xiaomei Cao collaborates with scholars based in China, Belarus and United States. Xiaomei Cao's co-authors include Jin‐Heng Li, Qi Zhang, Yang Sun, Jiaxi Chen, Xiubo Jiang, Yu Zeng, Jingyun Li, Qin Lu, Yuehua Zhou and Ping‐qing Gu and has published in prestigious journals such as Applied Microbiology and Biotechnology, Clinica Chimica Acta and Frontiers in Pharmacology.

In The Last Decade

Xiaomei Cao

20 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaomei Cao China 12 182 87 72 55 53 20 415
Tomomichi Sone Japan 12 170 0.9× 94 1.1× 104 1.4× 48 0.9× 21 0.4× 46 548
Meghan Cromie United States 11 189 1.0× 33 0.4× 41 0.6× 46 0.8× 28 0.5× 13 514
Richard Czerniak United States 9 189 1.0× 55 0.6× 54 0.8× 53 1.0× 32 0.6× 18 529
N. Bhagya India 10 226 1.2× 61 0.7× 148 2.1× 50 0.9× 47 0.9× 31 481
Haitang Xie China 14 332 1.8× 119 1.4× 87 1.2× 49 0.9× 32 0.6× 43 583
Yiqun Jia China 13 277 1.5× 78 0.9× 43 0.6× 25 0.5× 45 0.8× 22 600
Bixuan Jiang China 3 185 1.0× 200 2.3× 51 0.7× 32 0.6× 49 0.9× 3 558
Amit Joshi India 14 314 1.7× 47 0.5× 42 0.6× 44 0.8× 57 1.1× 26 612
Zegeng Li China 14 282 1.5× 51 0.6× 29 0.4× 57 1.0× 31 0.6× 49 524
Jana Gregorová Czechia 9 138 0.8× 59 0.7× 87 1.2× 43 0.8× 14 0.3× 42 358

Countries citing papers authored by Xiaomei Cao

Since Specialization
Citations

This map shows the geographic impact of Xiaomei Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomei Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomei Cao more than expected).

Fields of papers citing papers by Xiaomei Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomei Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomei Cao. The network helps show where Xiaomei Cao may publish in the future.

Co-authorship network of co-authors of Xiaomei Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomei Cao. A scholar is included among the top collaborators of Xiaomei Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomei Cao. Xiaomei Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Bing, et al.. (2022). Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population. Frontiers in Pharmacology. 13. 932686–932686. 6 indexed citations
2.
Huang, Tao, Yanfen Zhou, Xuanzhao Lu, et al.. (2021). Cordycepin, a major bioactive component ofCordyceps militaris, ameliorates diabetes‐induced testicular damage through the Sirt1/Foxo3a pathway. Andrologia. 54(1). e14294–e14294. 12 indexed citations
3.
4.
Chen, Jiaxi, Xiaotian Li, Xiaomei Cao, et al.. (2020). Limonin ameliorates dextran sulfate sodium-induced chronic colitis in mice by inhibiting PERK-ATF4-CHOP pathway of ER stress and NF-κB signaling. International Immunopharmacology. 90. 107161–107161. 32 indexed citations
5.
Cao, Xiaomei, Zhengshan Luo, Weizhu Zeng, et al.. (2017). Enhanced avermectin production by Streptomyces avermitilis ATCC 31267 using high-throughput screening aided by fluorescence-activated cell sorting. Applied Microbiology and Biotechnology. 102(2). 703–712. 33 indexed citations
6.
Zhou, Yuehua, Ping‐qing Gu, Jingyun Li, et al.. (2016). MicroRNA-29a induces insulin resistance by targeting PPARδ in skeletal muscle cells. International Journal of Molecular Medicine. 37(4). 931–938. 65 indexed citations
7.
Shang, Xue‐Jun, Juan Liu, Qiuyu Xu, et al.. (2013). Changes in expression and distribution of attractin in the testes of rats at different developmental stages. International Journal of Molecular Medicine. 32(3). 599–606. 1 indexed citations
8.
Ma, Bo, Xue‐Jun Shang, Qi Zhang, et al.. (2013). Rapid analysis of tadalafil in human blood plasma and seminal plasma by liquid chromatography/tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 77. 149–157. 20 indexed citations
9.
10.
Zhang, Xueyu, et al.. (2012). Pharmacokinetics and bioequivalence study of two digoxin formulations after single-dose administration in healthy Chinese male volunteers. Arzneimittelforschung. 61(11). 601–604. 2 indexed citations
11.
Dong, Xin, et al.. (2012). A sensitive LC‐MS/MS method for the simultaneous determination of amoxicillin and ambroxol in human plasma with segmental monitoring. Biomedical Chromatography. 27(4). 520–526. 30 indexed citations
12.
Huang, Jun, Yuan Tian, Zunjian Zhang, Jin‐Heng Li, & Xiaomei Cao. (2011). Pharmacokinetics and bioequivalence study of two mosapride citrate formulations after single-dose administration in healthy Chinese male volunteers. Arzneimittelforschung. 61(3). 167–172. 3 indexed citations
13.
Chen, Bing, Weimin Cai, Jin‐Heng Li, & Xiaomei Cao. (2009). Estimating N-acetyltransferase metabolic activity and pharmacokinetic parameters of isoniazid from genotypes in Chinese subjects. Clinica Chimica Acta. 405(1-2). 23–29. 5 indexed citations
14.
Ma, Jingjing, et al.. (2009). Effects of NAT2 polymorphism on SASP pharmacokinetics in Chinese population. Clinica Chimica Acta. 407(1-2). 30–35. 10 indexed citations
15.
Guo, Lian‐Qing, Qiaoyun Chen, Yuxiu Liu, et al.. (2007). Different Roles of Pummelo Furanocoumarin and Cytochrome P450 3A5*3 Polymorphism in the Fate and Action of Felodipine. Current Drug Metabolism. 8(6). 623–630. 16 indexed citations
16.
17.
Cao, Xiaomei, et al.. (2006). Pyrethroid resistance and distribution ofkdrallele inCulex pipiens pallensin north China. International Journal of Pest Management. 53(1). 25–34. 15 indexed citations
18.
Chen, Bing, et al.. (2005). The influence of NAT2 genotypes on the plasma concentration of isoniazid and acetylisoniazid in Chinese pulmonary tuberculosis patients. Clinica Chimica Acta. 365(1-2). 104–108. 27 indexed citations
19.
Zhu, Xinle, et al.. (2004). Photocatalytic degradation of pesticide pyridaben in suspension of TiO2: identification of intermediates and degradation pathways. Journal of Molecular Catalysis A Chemical. 214(2). 293–300. 28 indexed citations
20.
Lü, Jianfeng, Xiaomei Cao, Zhihai Liu, et al.. (1998). Genetic analysis of N-acetyltransferase polymorphism in a Chinese population.. PubMed. 19(4). 347–51. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomomichi Sone Breakdown of academic impact, for papers by Meghan Cromie Breakdown of academic impact, for papers by Richard Czerniak Breakdown of academic impact, for papers by N. Bhagya Breakdown of academic impact, for papers by Haitang Xie Breakdown of academic impact, for papers by Yiqun Jia Breakdown of academic impact, for papers by Bixuan Jiang Breakdown of academic impact, for papers by Amit Joshi Breakdown of academic impact, for papers by Zegeng Li Breakdown of academic impact, for papers by Jana Gregorová
Rankless by CCL
2026